Oral estramustine and oral etoposide for hormone-refractory prostate cancer

By Dimopoulos M.A.   Panopoulos C.   Bamia C.   Deliveliotis C.   Alivizatos G.   Pantazopoulos D.   Constantinidis C.   Kostakopoulos A.   Kastriotis I.   Zervas A.   Aravantinos G.   Dimopoulos C.  

Urology, Vol. 50, Iss. 5, 1997-11 ,pp. : 754-758

Elsevier

Access to resources Recommend Favorite

Inhibition of prostate cancer growth by 9-aminocamptothecin and estramustine

By Naik H.   Lehr J.E.   Pienta K.J.  

Urology, Vol. 48, Iss. 3, 1996-09 ,pp. : 508-511

Elsevier

Access to resources Recommend Favorite

A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancer

By Pienta K.J.   Redman B.G.   Bandekar R.   Strawderman M.   Cease K.   Esper P.S.   Naik H.   Smith D.C.  

Urology, Vol. 50, Iss. 3, 1997-09 ,pp. : 401-407

Elsevier

Access to resources Recommend Favorite

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer

By Clark P.E.   Peereboom D.M.   Dreicer R.   Levin H.S.   Clark S.B.   Klein E.A.  

Urology, Vol. 57, Iss. 2, 2001-02 ,pp. : 281-285

Elsevier

Access to resources Recommend Favorite

Differential effect of chromogranin A fragments on invasion and growth of prostate cancer cells in vitro

By Nagakawa O.   Fujiuchi Y.   Fuse H.   Saiki I.  

Urology, Vol. 62, Iss. 3, 2003-09 ,pp. : 553-558

Elsevier

Access to resources Recommend Favorite